Thursday, June 20, 2013 9:26:21 PM
The delay opened up the possibility of financiers now lowering the sp to gain increased share count as the price drops.
Some believe that iroqious will now continue to drive the price down. Others not so negative believe it would be in their best interest considering the possible huge gain after markman/settlement/litigation to just convert the financing at .35 and hold the shares.
Now with the toxic financing falling before the markman there is a slight chance that the company will have to dilute with the increase in A/S and may trigger the company to do an R/S earlier.
There is no way to be for sure on any of these issues as they are issues that can not be predicted. But many will try...watch.
The fact of the matter is...Delays cause selling, bad financing is detrimental to the stock price.
In patent plays I've come to find that stability in the stock price is unusual as it sways with the direction of sentiment. Playing the moves up and down can be more profitable than holding that stock long term. The winds change quite often with over the top responses to any news.
All depends on the risk/reward but it's the time frame for that risk/reward that causes the most damage.
Here today we saw the risk increase along with the time frame which resulted in the drop. Wouldn't be surprised to see it continue through tomorrow morning before stabalizing.
There where IMO a lot of people in for the pre-markman run-up planning on taking a good chunk off the table before July 15th the shareholder meeting to ratify the R/S and A/S. Those have or will exit the stock.
Everything is IN MY OPINION!!!
Recent WDDD News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 01:27:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:16:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:47:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:21 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM